Consolidated Balance Sheets - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Assets
Cash and cash equivalents	$ 1,276,654	$ 2,038,150
Inventory		22,666
Prepaid expense and other current assets	26,580	23,635
Total current assets	1,303,234	2,084,451
Patents, net	146,456	182,386
Property and equipment, net	14,010	26,997
Total assets	1,463,700	2,293,834
Liabilities and Stockholders’ Deficit
Accounts payable and accrued expenses	115,313	159,300
Advances from investors	104,952	777,258
Convertible notes payable – related party	513,356	886,481
Total current liabilities	733,621	1,823,039
Total liabilities	733,621	1,823,039
Commitments and contingencies
Stockholders’ equity
Preferred stock, $0.01 par value: Authorized shares – 10,000,000, Issued and outstanding shares – 0 at December 31, 2018 and December 31, 2017, respectively
Common stock, $0.01 par value: Authorized shares – 100,000,000, Issued and outstanding shares –39,117,524 and 23,156,563 at December 31, 2018 and 2017, respectively	391,175	231,565
Additional paid-in capital	3,527,238	2,123,205
Accumulated deficit	(3,188,334)	(1,883,975)
Total stockholders’ equity	730,079	470,795
Total liabilities and stockholders’ equity	$ 1,463,700	$ 2,293,834